AXIM.US Axim Biotechnologies Inc

Healthcare Biotechnology USA Stocks
0.0030 USD
Close of Nov 14, 2026
0.0025 0.0290
Market cap
USD 1.05M
P/E
-
P/B
2.86x
ROE
-
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is AXIM.US undervalued?

Graham number

The Graham number of Axim Biotechnologies Inc cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Axim Biotechnologies Inc fundamental analysis

No fundamental analysis for Axim Biotechnologies Inc yet.

Axim Biotechnologies Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Axim Biotechnologies Inc

AXIM Biotechnologies, Inc. develops diagnostic healthcare solutions for ophthalmological conditions. It develops and commercializes two point-of-care diagnostic tests to assist eye-care physicians in detecting and quantifying biomarkers associated with aqueous deficient dry eye disease and non-specific allergic conjunctivitis, including ocular total immunoglobulin E allergy test and lactoferrin ADDE test. It also operates a full-service center for custom biomarker and biopha…

Full company profile